文献速递糖尿病

生长分化因子15与糖尿病发病风险正相关:Malmö饮食与癌症-心血管队列

Growth differentiation factor 15 is positively associated with incidence of diabetes mellitus: the Malmö Diet and Cancer-Cardiovascular Cohort.
PubMed 文献 · Diabetologia · 2018-10-22

基于Malmö饮食与癌症-心血管队列4360名基线无糖尿病的中年城市居民,随访19.0±5.16年,采用Cox比例风险回归分析基线空腹血浆GDF-15与糖尿病发病的关系,发现GDF-15水平升高与糖尿病发病风险正相关。

要点

  • GDF-15每升高1个SD,糖尿病发病风险增加17%(HR 1.17,95%CI 1.07–1.28)。
  • GDF-15最高四分位组较最低四分位组糖尿病发病HR为1.43(95%CI 1.11–1.83)。
  • GDF-15或可用于识别糖尿病发病风险人群,尤其是≤60岁者。

核心结论

  • 基线循环GDF-15水平与未来糖尿病发病风险正相关,可能有助于识别糖尿病发病风险人群。
  • 该关联在无空腹血糖受损者中明显,且随年龄增长趋于减弱。

研究设计与样本

  • 1991–1994年纳入Malmö饮食与癌症-心血管队列中4360名无糖尿病个体,测量基线空腹血浆GDF-15。
  • 平均年龄57.4±5.96岁,男性占38.6%,随访19.0±5.16年,采用Cox比例风险回归分析并校正既定混杂因素。
  • 敏感性分析进一步校正C反应蛋白(CRP)水平。

主要发现

  • 随访期间621人发生糖尿病。
  • GDF-15第四分位较第一分位的多变量校正HR为1.43(95%CI 1.11–1.83;趋势p=0.007)。
  • GDF-15每升高1个SD的多变量校正HR为1.17(95%CI 1.07–1.28;p<0.001)。
  • 按基线空腹血糖分组,GDF-15与糖尿病风险的关联仅见于无空腹血糖受损组(n=3973)。
  • 每SD升高GDF-15的HR在≤55岁、56–60岁和>60岁者分别为1.24(95%CI 1.08–1.42)、1.19(95%CI 1.00–1.41)和1.04(95%CI 0.89–1.23)。

关键数值与推荐

  • 敏感性分析校正CRP后,GDF-15每SD升高的HR为1.21(95%CI 1.09–1.35;p=0.015)。
  • 校正CRP后,GDF-15第四分位较第一分位的HR为1.30(95%CI 1.01–1.67;趋势p=0.061),不再显著。

临床怎么用

  • 在中年城市人群中,可考虑将GDF-15作为糖尿病风险识别的潜在生物标志物。
  • 对≤60岁人群,GDF-15与糖尿病风险的关联更明显,可能更适合用于该年龄段的风险分层。

局限性

  • 原文摘要未系统报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Growth differentiation factor 15 (GDF-15) is an anti-inflammatory cytokine of the transforming growth factor-β superfamily. Circulating levels of GDF-15 are associated with hyperglycaemia among people with obesity or diabetes, but longitudinal evidence on the association between GDF-15 levels and diabetes risk is scarce. Our aim was to explore whether circulating levels of GDF-15 at baseline are positively associated with future diabetes incidence in a middle-aged urban population. METHODS: Between 1991 and 1994, baseline fasting plasma GDF-15 levels were measured in 4360 individuals without diabetes (mean age 57.4 ± 5.96 years, 38.6% men) who were participants in the Malmö Diet and Cancer-Cardiovascular Cohort. After a follow-up of 19.0 ± 5.16 years (mean ± SD), Cox proportional hazards regression analysis was used for the study of the relationship between baseline GDF-15 and incident diabetes, with adjustment for established confounders. A sensitivity analysis included further adjustment for levels of C-reactive protein (CRP). RESULTS: During the follow-up period, 621 individuals developed diabetes. The multivariate-adjusted HR for diabetes incidence was 1.43 (95% CI 1.11, 1.83; p for trend = 0.007) for the fourth compared with the first quartile of GDF-15, and was 1.17 (95% CI 1.07, 1.28; p < 0.001) per SD increase of GDF-15. If participants were grouped according to baseline fasting glucose, the association between GDF-15 and diabetes risk was only evident in the group without impaired fasting glucose (n = 3973). The association tended to be less significant with increasing age: multivariate-adjusted HRs for diabetes per SD increase of GDF-15 were 1.24 (95% CI 1.08, 1.42), 1.19 (95% CI 1.00, 1.41) and 1.04 (95% CI 0.89, 1.23) for participants aged ≤55, 56-60 (>55 and ≤60) and >60 years, respectively. With adjustment for levels of CRP, the HR per SD increase of GDF-15 (1.21, 95% CI 1.09, 1.35) was significant (p = 0.015), but the HR for the fourth compared with the first quartile of GDF-15 was not significant (HR 1.30; 95% CI 1.01, 1.67; p for trend = 0.061). CONCLUSIONS/INTERPRETATION: GDF-15 may be useful for identification of people with a risk of incident diabetes, especially if those people are ≤60 years old.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Bao X, Borné Y, Muhammad IF, et al. Growth differentiation factor 15 is positively associated with incidence of diabetes mellitus: the Malmö Diet and Cancer-Cardiovascular Cohort. Diabetologia. 2018. PMID: 30350239. doi:10.1007/s00125-018-4751-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。